Researchers have developed an evidence-based consensus guidelines for genetic testing and counseling for patients with amyotrophic lateral sclerosis (ALS), a neurodegenerative disease that affects the cells in the brain and spine.
Click here for original story, Guidelines follow advances in ALS gene discovery, ongoing gene therapy trials
Source: ScienceDaily